scispace - formally typeset
A

Antonin Faes

Researcher at École Polytechnique Fédérale de Lausanne

Publications -  63
Citations -  2345

Antonin Faes is an academic researcher from École Polytechnique Fédérale de Lausanne. The author has contributed to research in topics: Anode & Solid oxide fuel cell. The author has an hindex of 22, co-authored 60 publications receiving 1972 citations. Previous affiliations of Antonin Faes include Swiss Center for Electronics and Microtechnology & Swiss Federal Laboratories for Materials Science and Technology.

Papers
More filters
Journal ArticleDOI

A Review of RedOx Cycling of Solid Oxide Fuel Cells Anode

TL;DR: The effects and parameters influencing RedOx cycles of the Ni-ceramic anode are reviewed and solutions for RedOx instability are described from the point of view of the system, stack design, cell design, new materials and microstructure optimization.
Journal ArticleDOI

Nickel–Zirconia Anode Degradation and Triple Phase Boundary Quantification from Microstructural Analysis

TL;DR: In this paper, an anode degradation model is proposed to describe the gradual degradation of the anode due to nickel particle sintering and the concomitant loss of TPB.
Journal ArticleDOI

Experimental and Theoretical Investigation of Degradation Mechanisms by Particle Coarsening in SOFC Electrodes

TL;DR: In this article, performance degradation data obtained on single solid oxide fuel cells tested at 850°C with air and humidified H2 and using Ni-YSZ anode supported cells are presented.
Journal Article

Nickel-Zirconia Anode Degradation and Triple Phase Boundary Quantification from Microstructural Analysis (vol 9, pg 841, 2010)

TL;DR: In this paper, the authors present a Web of Science Record created on 2011-12-16, modified on 2016-08-09 and used for the publication of their paper.
Journal ArticleDOI

The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia

TL;DR: It is of great clinical interest to develop cosolvent formulations with up to 20% w/v of magnetic microparticles that show reduced toxicity and centered tumor implantation.